Chris Sampson looks at a systematic review of the economics of Internet interventions for common mental health problems such as depression and anxiety.
[read the full story...]
Can we steer drug-using offenders away from crime and into treatment? Chris Sampson explores a study of the cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs.
[read the full story...]
Susie Johnson reports on the FolATED RCT and economic evaluation of folic acid for depression. The study finds no evidence that folic acid is clinically effective or cost-effective in augmenting antidepressants and speculates instead that methylfolate may be a better candidate for future research.
[read the full story...]
Our resident Elf Economist, Chris Sampson, reports on a new systematic review of economic evaluations for borderline personality disorder. Are any cost-effective?
[read the full story...]
Chris Sampson reports on a recent systematic review and critical appraisal of economic evaluations in bipolar disorder. He finds that there’s a pressing need for new studies, especially discrete event simulations.
[read the full story...]
Andrew Jones and Chris Sampson report on a systematic review and economic evaluation of cytisine and varenicline for smoking cessation, which finds that both drugs are clinically effective compared with placebo.
[read the full story...]
Elf economist Chris Sampson reports on the economic evaluation of the CoBalT RCT, which finds that CBT is cost-effective for treatment resistant depression in primary care.
[read the full story...]
Chris Sampson looks at the economic outcomes of a recent RCT of joint crisis plans to reduce compulsory treatment for people with psychosis. The study reports the potential for gains specifically among Black patients.
[read the full story...]
Health Economist Christopher Sampson reports on a recent systematic review and meta-analysis, which shows health-related quality of life utility values vary between studies and economic models should consider this.
[read the full story...]
This recent report, commissioned by the European Commission and compiled by RAND Europe, aims to summarise economic evaluation evidence on the impact of integrated care. The authors restricted their evidence search to systematic reviews and meta analyses, which is understandable as this is described as a rapid review but the authors acknowledge this has limitations, [read the full story…]
